论文部分内容阅读
目的:研究美罗培南治疗重症肺炎的临床效果。方法:对自2014年12月至2015年11月间在我院的71例重症肺炎患者采用美罗培南进行治疗研究,并对患者治疗的评价指标进行统计分析。结果:71例患者的总有效率为85.92%,死亡率为2.82%,治疗前后的临床指标发生显著改善,比较差异值P<0.05,具有统计学意义。结论:在治疗重症肺炎时采用美罗培南具有较好的治疗有效率,并可明显改善患者的临床指标,值得临床推广应用。
Objective: To study the clinical effect of Meropenem in the treatment of severe pneumonia. Methods: Seventy-one patients with severe pneumonia in our hospital from December 2014 to November 2015 were treated with Meropenem and the statistical analysis was made on the evaluation indexes of the patients’ treatment. Results: The total effective rate of 71 patients was 85.92%, the mortality rate was 2.82%. The clinical indexes before and after treatment significantly improved, with a difference of P <0.05, with statistical significance. Conclusion: The use of Meropenem in the treatment of severe pneumonia has a good therapeutic efficiency, and can significantly improve the clinical indicators of patients, it is worth promoting the clinical application.